INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOLLENCREST CAPITAL MANAGEMENT | 15,000 | $278,100 | 0.03% |
| Carmignac Gestion | 85,271 | $1,580,924 | 0.03% |
| Pictet Asset Management Holding SA | 1,205,093 | $22,342,424 | 0.03% |
| GABELLI FUNDS LLC | 178,800 | $3,314,952 | 0.03% |
| Quarry LP | 6,278 | $116,394 | 0.03% |
| BALYASNY ASSET MANAGEMENT L.P. | 702,900 | $13,031,766 | 0.03% |
| Renaissance Technologies | 825,800 | $15,310 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 12,866 | $238,536 | 0.02% |
| E Fund Management Co., Ltd. | 15,728 | $292 | 0.02% |
| Prospera Financial Services Inc | 31,262 | $579,567 | 0.02% |
| TUDOR INVESTMENT CORP ET AL | 115,800 | $2,146,932 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 193,940 | $3,595,648 | 0.02% |
| UBS Group AG | 2,999,188 | $55,604,946 | 0.02% |
| NATIXIS | 120,000 | $2,224,800 | 0.02% |
| FORA Capital, LLC | 10,009 | $185,567 | 0.02% |
| D. E. Shaw & Co., Inc. | 791,335 | $14,671,351 | 0.02% |
| Cubist Systematic Strategies, LLC | 92,281 | $1,710,890 | 0.01% |
| State of Wyoming | 3,213 | $59,569 | 0.01% |
| Connor, Clark & Lunn Investment Management Ltd. | 126,550 | $2,346,237 | 0.01% |
| ALLIANCEBERNSTEIN L.P. | 1,542,896 | $28,605,292 | 0.01% |
External links
This page lists INTERCEPT PHARMACEUTICALS IN's shareholders in Q3 2023. To view INTERCEPT PHARMACEUTICALS IN's shareholder history, click here.